Journal of Bacteriology, June 2000, p. 3197-3203, Vol. 182, No. 11
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Medical Microbiology and Immunology, University of Wisconsin Medical School, Madison, Wisconsin 53706
Received 30 December 1999/Accepted 6 March 2000
| |
ABSTRACT |
|---|
|
|
|---|
A chromosomal insertion of transposon Tn917 partially restores the expression of protease and alpha-toxin activities to PM466, a genetically defined agr-null derivative of the wild-type Staphylococcus aureus strain RN6390. In co-transduction experiments, transposon-encoded erythromycin resistance and a protease- and alpha-toxin-positive phenotype are transferred at high frequency from mutant strains to agr-null strains of S. aureus. Southern analysis of chromosomal DNA and sequence analysis of DNA flanking the Tn917 insertion site in mutant strains revealed that the transposon interrupted a 498-bp open reading frame (ORF). Similarity searches using a conceptual translation of the ORF identified a region of homology to the known staphylococcal global regulators AgrA and SarA. To verify that the mutant allele conferred the observed phenotype, a wild-type allele of the mutant gene was introduced into the genome of a mutant strain by homologous recombination. The resulting isolates had a restored agr-null phenotype. Virulence factor gene expression in mutant, restored mutant, and wild-type strains was quantified by measuring alpha-toxin activity in culture supernatant fluids and by Northern analysis of the alpha-toxin transcript. We named this ORF rot (for repressor of toxins) (GenBank accession no. AF189239) because of the activity associated with rot::Tn917 mutant strains.
| |
INTRODUCTION |
|---|
|
|
|---|
In Staphylococcus aureus, the expression of many virulence factors is coordinately regulated. The genetics of this regulation is largely understood in terms of the function of agr and sar (30). Together, the components of these loci form part of a complex pathway that leads to decreased transcription of select cell surface virulence factor genes and increased transcription of regulated extracellular toxins and enzymes (see Fig. 1.) (6, 16, 17, 21, 31). Translational control of alpha-toxin by the agr-sar system has also been demonstrated (28, 32). In agr or sar mutant strains, regulated cell surface proteins (e.g., coagulase, fibronectin binding protein, and protein A) are produced throughout the exponential and postexponential phases of growth. This is in contrast to wild-type strains that only produce these proteins during exponential growth. Furthermore, in agr and sar mutant strains, many extracellular toxins and enzymes that are normally present in postexponential phase cultures (e.g., alpha-toxin, metalloprotease, and serine protease) are reduced to as low as 5% of their normal levels (17, 32).
The agr (accessory gene regulator) locus encodes a
self-inducing, pheromone-sensing, signal transduction circuit (Fig.
1A). One of two divergent agr
messages is transcribed from a promoter designated P2 (33).
This message, RNAII, encodes four proteins, AgrA, AgrB, AgrC, and AgrD.
Two of these agr-encoded proteins share sequence homology
with elements of other bacterial two-component signal transduction
systems: AgrC and AgrA function as sensor and regulator proteins,
respectively. The activating signal of the agr system is a
pheromone encoded within the prepeptide protein AgrD. AgrB is believed
to be the enzyme responsible for the maturation and/or secretion of the
8-amino-acid peptide pheromone (18, 19).
|
The agr system up-regulates its function when AgrC binds the AgrD-derived signal (30). Like other bacterial sensor proteins, the binding of the signal results in the autophosphorylation of AgrC and, presumably, a concomitant activating conformational change (25). The phosphate group on AgrC is then thought to be transferred to the regulator protein AgrA, resulting in the activation of AgrA. Unlike other bacterial signal transduction systems in which the activated regulator protein directly initiates the transcription of target promoters, AgrA functions with the translation product of an unlinked locus named sar (staphylococcal accessory protein regulator) (7). The sar product, SarA, binds a region of DNA between the two agr promoters, and in conjunction with activated AgrA it up-regulates transcription of the agr messages (6, 16, 29). The result of the increased transcription is an amplification of the circuit encoded by RNAII and high-level production of a 510-ribonucleotide message known as RNAIII (17, 29, 32).
The current understanding is that RNAIII is involved in both repressing the transcription of cell surface protein genes and activating the transcription of extracellular protein genes (32, 33). In the case of alpha-toxin, a direct interaction between RNAIII and the alpha-toxin message is required for full translation (28, 29). When synthesized from a heterologous promoter in an agr-null mutant, RNAIII returns a wild-type pattern of virulence factor messages and translation products (28, 39; our unpublished data). Mutational analysis of RNAIII has shown that delta-toxin does not play a role in the regulation of virulence factor gene expression, suggesting that the message is the effector molecule of the agr-sar system (19, 32, 33).
An additional layer of complexity in this model is added by the
observation that SarA is transcribed on three different overlapping messages known from largest to smallest as A, C, and B (3). These messages are initiated from distinct upstream promoters named P1,
P3, and P2, respectively. Each message ends at a common terminator
downstream of the SarA open reading frame. The P1 and P2 promoters are
dependent on
SA, the primary sigma factor in S. aureus, while the P3 promoter is dependent on
SB, a
multiple-stress-responsive sigma factor (23, 39). These data
can be linked to the observation that virulence factor production is
regulated by environmental conditions. For example, SarA message and
levels of alpha-toxin are both elevated when the bacteria are exposed
to oxidative stress (6). Additionally, SarA, its messages,
or unidentified translation products encoded by the messages may play a
direct role in virulence factor regulation. This hypothesis is based on
the observation that decreases in transcription of the gene encoding
cell protein A requires a different trans-encoded
sar message in sar as compared to agr
mutants of S. aureus (8).
Despite the progress made in understanding the agr-sar system, the best available evidence suggests that additional regulatory factors are required for virulence factor production (2, 11, 12, 39). One example of this difference is seen with alpha-toxin. This hemolysin is concomitantly transcribed, translated, and secreted 2 h after the appearance of RNAIII; however, RNAIII remains elevated while alpha-toxin production falls within 1 h of reaching peak production (39). In addition, unidentified regulatory molecules have also been invoked to explain the decrease in alpha-toxin message seen when S. aureus is treated with protein synthesis inhibitors (2). In the present study, we used transposon Tn917 mutagenesis to identify a gene that encodes a previously undescribed regulator of alpha-toxin.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains, phage, plasmids, media, growth
conditions, and virulence factor assays.
Bacteria, bacteriophage,
and plasmids used in this study are described in Table
1. S. aureus was cultivated in
tryptic soy broth (TSB) (Difco Laboratories, Detroit, Mich.) and
incubated at 37°C with rotary agitation at 200 rpm or grown on
tryptic soy agar plates (TSA). Escherichia coli was grown at
37°C in Luria-Bertani broth with agitation or on Luria-Bertani agar.
Antibiotic-resistant staphylococci were selected and maintained in
tetracycline (10 µg ml
1) or erythromycin or
chloramphenicol (5 µg ml
1). Resistant E. coli were grown in media augmented with 100 µg of ampicillin
ml
1. The method used for quantitative measurement of
alpha-toxin has been previously described (15, 27). Assays
for coagulase and protease have been described by Hart et al.
(15).
|
DNA isolation.
Chromosomal DNA was isolated from S. aureus using the method of Dyer and Iandolo (13).
Staphylococcal plasmid DNA was purified using a Qiagen (Chatsworth,
Calif.) Plasmid Mini Kit. The plasmid isolation procedure was modified
by incubating the cell suspension in P1 buffer containing 100 µg of
recombinant lysostaphin ml
1 (AMBI UK, Trowbridge, United
Kingdom) for 30 min at 37°C. The procedure was further modified by
removal of the precipitate formed after the addition of neutralization
buffer by centrifugation for 30 min. Routine procedures were used to
isolate DNA from E. coli (1).
Recombinant techniques.
Plasmids were constructed and
amplified in E. coli strain DH5
using standard
recombinant DNA techniques (1). Restriction endonucleases,
DNA modification enzymes, and polymerases were obtained from Promega
(Madison, Wis.) and used as recommended by the manufacturer.
11 lysates were
obtained from infected strains grown in overlaid soft agar (TSB, 0.5 mM
CaCl2, 0.5% agar) and sterilized by passage through 0.2-µm-pore-size filters, and titers were determined on S. aureus strain RN6390. Transductions consisted of 5 × 1011 CFU ml
1 of exponentially grown bacteria
in TSB containing 0.5 mM CaCl2 and 5 × 1010 PFU ml
1 of bacteriophage in a total of
0.6 ml. After 5 min at room temperature, 1.5 ml of TSB containing 0.5 mM CaCl2 was added, and the tubes were incubated for 20 min
at 37°C. Following the addition of 1 ml of 0.2 mM sodium citrate, the
cells were harvested by centrifugation at 4 × 103 × g for 20 min, resuspended in 1 ml of 0.2 mM sodium citrate, and plated on TSA supplemented with 2 mM sodium
citrate and the appropriate antibiotic. Transductional frequencies,
when reported, were based on scoring of at least 65 colonies.
Transformations of S. aureus were conducted using the
electrotransformation procedure of Kraemer and Iandolo (22).
All plasmid DNA initially isolated from E. coli was
introduced into S. aureus RN4220 prior to introduction to
other strains of S. aureus. Allelic exchange in S. aureus utilized pSPT181(ts)-based plasmids with the conditions for
plasmid integration and cointegrate resolution that have been described
in detail by Janzon and Arvidson (17).
Construction of S. aureus strain PM466. To create PM466, the agr locus was deleted from strain RN6390 by allelic exchange using plasmid pJM48. Plasmid pJM48 was constructed in multiple steps. Initially, a 3.3-kb ClaI-HpaI Agr-encoding fragment was removed from plasmid pRN6650, creating pJM33. The 2.8-kb EcoRI-HindIII fragment from pJM33 that contains agr-flanking DNA was then cloned into similar sites in pBC SK (Stratagene, La Jolla, Calif.). This fragment was removed from pBC SK by digestion with PstI and transferred into similar sites in the temperature-sensitive shuttle vector pSPT181(ts), creating pJM48.
Transposon Tn917 mutagenesis and phenotypic screens. Strain PM466 was subjected to mutagenesis with transposon Tn917 carried on plasmid pTV1 (41). To overcome the low transformation efficiency of S. aureus, a colony of PM466 harboring pTV1 was grown at 32°C, the permissive temperature, on TSA containing chloramphenicol, to create a pool of bacteria with pTV1. Mutant bacteria were selected at 42°C and screened for protease activity on nutrient agar (38) with 5% skim milk (Difco Laboratories) and hemolytic activity on blood agar base (Difco Laboratories) supplemented with 5% rabbit blood.
Southern and Northern hybridization. Digested staphylococcal chromosomal DNA was subjected to electrophoresis through 0.7% agarose gels, transferred to nylon membranes (MagnaGraph; Micron Separators Inc., Westborough, Mass.), and probed using the Genius system (Boehringer Mannheim, Indianapolis, Ind.) as instructed by the manufacturer. Hybridizations used a randomly primed digoxigenin-labeled 6.1-kb BamHI fragment from pRN6650 that contains agr plus flanking DNA or a 1.2-kb HindIII probe from pIM36 that encodes the transposase of transposon Tn551, standard buffer plus 50% formamide for prehybridization and hybridization, and stringent washes performed at 68°C (27). Detection used the chemiluminescent substrate disodium 3-(4-methoxyspiro{1,2-dioxetane-3,2'-(5'-chloro)tricyclo[3.3.2.237]decan}-4-yl) phenyl phosphate (CSPD) (Boehringer Mannheim).
Total cellular RNA was isolated from 10-h cultures of S. aureus by the method of Hart et al. (15) and purified using RNAeasy (Qiagen). Electrophoresis of RNA was conducted in 1% LE agarose (FMC Bioproducts, Rockland, Maine) glyoxal gels. The RNA was transferred to a nylon membrane (MagnaGraph) and probed with a ClaI-XbaI fragment from pIM42 that encodes part of RNAIII or a SpeI-HindIII fragment from plasmid pJM531 that encodes alpha-toxin. The probes were digoxigenin labeled and hybridized using high-concentration sodium dodecyl sulfate buffer at 50°C. Stringent washes were performed at 65°C, and detection was carried out with CSPD. Levels of message were compared using Multi-Analyst Version 1.02 software (Bio-Rad Laboratories, Hercules, Calif.).Inverse PCR and nucleotide sequencing.
Inverse PCRs
contained chromosomal DNA from strains PM614, PM615, or PM616 digested
with either EcoRI or PstI and self-ligated at a
concentration of 5 ng of DNA µl
1. The
Tn917-specific outward facing primers were
5'-GAGCATATCCACTTTTCTTGGAG-3' and
5'-CACAATAGAGAGATGTCACGTC-3' (GenBank accession no. M11180). DNA was amplified by the method of Coen (10). The nucleotide sequence for rot was obtained using an Applied Biosystems
373A or 377 DNA Sequencer with dye terminator cycle sequencing
chemistry (Perkin-Elmer, Foster City, Calif.) on Qiagen purified DNA.
Template DNA consisted of a pool of three independently amplified PCR
products. Sequencing primers were designed to extend the newly acquired sequence. Additional S. aureus sequence data were obtained
from The Institute for Genomic Research (website at
http://www.tigr.org). Data were analyzed using the Wisconsin
Genetics Computer Group sequence analysis software package Version 9.1.
Construction of S. aureus strain PM720. PM720 was created by allelic exchange using S. aureus PM614 and plasmid pJM202. Plasmid pJM202 is plasmid pSPT181(ts) with a 1.3-kb PCR fragment generated from the wild-type S. aureus strain RN6390 using primers that correspond to sequence upstream and downstream of rot, 5'-CAAAGCCTGACACGACAATCC-3' and 5'-CTGAAAGATGAGACAGTAGATG-3', respectively. To construct pJM202, the rot-containing PCR fragment was cloned into plasmid pCRII (+) (Invitrogen, Carlsbad, Calif.) and verified by restriction endonuclease and sequence analysis. The rot fragment in pCRII was removed by digestion with EcoRI and moved into a similar site within the multiple-cloning site of pSPT181(ts).
| |
RESULTS |
|---|
|
|
|---|
Construction of S. aureus strain PM466.
Strain
PM466 is a new agr-null derivative of S. aureus
RN6390 created by allelic exchange using plasmid pJM48. The deletion in
PM466 encompasses the entire agr P2 operon and the first
379-bp of the P3 transcript. The expected chromosomal deletion was
confirmed in strain PM466 by Southern analysis (Fig.
2). Measurements of virulence factor
activity demonstrated that post-exponential-phase culture supernatant
fluids from PM466 had less than 5% of the protease and alpha-toxin
activities associated with RN6390. Coagulase activity was approximately
10-fold higher in PM466 than in the wild-type control. RNAIII in PM466
could not be detected by Northern analysis (data not shown).
|
Transposon Tn917 mutagenesis and transductional analysis. Strain PM466 was subjected to mutagenesis with transposon Tn917. Approximately 2 × 104 bacteria with chromosomal insertions of the transposon were screened for proteolytic activity on skim milk agar, both with and without erythromycin. Eleven protease-positive strains were isolated. To rule out mutations in genes that only activate protease expression, the erythromycin-resistant, protease-positive strains were screened for hemolytic activity on rabbit blood agar plates. Nine of the original eleven isolates had alpha-toxin activity. The loss of plasmid pTV1 from these nine strains was confirmed by testing for vector-encoded antibiotic resistance on TSA supplemented with the MIC of chloramphenicol. The lack of growth of the nine strains in this medium suggested that the erythromycin resistance was mediated by a chromosomal insertion of the transposon.
To confirm the linkage between the transposon and the genetic lesion causing the restored phenotype, DNA surrounding the transposon from the presumptive mutant strains was back-transferred into the agr-null strains PM466 and RN6911 by transduction using bacteriophage
11 in independent experiments. In independent
experiments, the protease- and alpha-toxin-positive phenotype was shown
to cotransfer with transposon-encoded erythromycin resistance in four
of the nine isolates. No differences in phenotype were observed between mutations in the two agr-null genetic-backgrounds.
Transduction of the erythromycin resistance marker into PM466 resulted
in the isolation of strains PM614, PM615, and PM616. In these
experiments, more than 98% of the transductants had a protease- and
alpha-toxin-positive phenotype. In the remaining strains, genetic
linkage could not be verified.
Southern analysis of chromosomal DNA from PM614, PM615, and PM616 using
a Tn917-derived probe suggested that a single gene conferred
the restored extracellular protein phenotype. Single digests of the
chromosomal DNA using four different restriction endonucleases that do
not cut within Tn917 resulted in an identical pattern of
hybridizing DNA fragments (data not shown). These data suggest that the
chromosomal insertion of the transposon in the three strains occurred
within the same gene.
DNA surrounding the insertion site of the transposon from strains
PM614, PM615, and PM616 was amplified by inverse PCR, and the
nucleotide sequence of approximately 2 kb of DNA flanking the
transposon insertion site was determined. The size of the inverse PCR
products was consistent with values predicted from Southern analysis of
the protease- and alpha-toxin-positive transductants (data not shown).
With each of these strains, the probe-hybridizing EcoRI
fragment was 9 kb and the inverse PCR product, minus
Tn917 DNA, was approximately 4 kb. Furthermore, in each of
these strains, we found the nucleotide duplication that occurs upon the
transposition of Tn917.
Nucleotide sequence analysis of the inverse PCR products indicated that
the transposon insertion site in PM614 and PM616 was identical. In
strain PM615, the transposon had inserted into a different site within
the same gene. The open reading frame for the interrupted gene is 498 bp in length (GenBank accession no. AF189239). The predicted protein
begins at an ATG translational start and terminates after 161 amino
acid residues at a TAA stop. Alternatively, protein initiation from a
downstream ATG start would result in a 141-amino-acid residue protein.
A BLASTP search using a conceptional translation of the predicted
161-amino-acid protein identified hypothetical proteins (GenBank
accession no. U89914 and Swiss-protein accession no. P54182) and a
region of homology to S. aureus AgrA and SarA as well as
Staphylococcus epidermidis AgrA (Fig.
3). The transposon-inactivated gene was
named rot (repressor of toxins) because loss of a wild-type allele results in the restoration of protease and alpha-toxin activities to S. aureus PM466 and to reflect the fact that
it has homology to known transcriptional regulators.
|
Verification and initial characterization of the rot
mutation.
As viewed on indicator plates, inactivation of
rot restores a post-exponential-phase protease- and
alpha-toxin-positive phenotype to the agr-null strain of
S. aureus PM466. To quantify the effect of the
rot mutation on virulence factor production, we compared alpha-toxin activity in culture supernatant fluids from strains RN6390,
PM466, PM614, and PM720 (Fig. 4). PM466,
the agr-null strain, has approximately 4% of the activity
associated with RN6390, its wild-type parental strain. Compared to the
activity seen with PM466, the rot mutation in PM614 results
in a 40-fold increase in alpha-toxin activity. This level is
approximately half that associated with a wild-type strain. Similar
results were seen with PM615 (data not shown).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
We have identified a locus in S. aureus that encodes a regulator of virulence factors. This locus was named rot because our data suggests that the predicted gene product acts as a repressor of toxins. In an agr-null background, a mutation in rot increases the expression of protease and alpha-toxin. In addition, we showed increased transcription of the gene encoding alpha-toxin in an agr rot double mutant strain.
Based upon the fact that protein synthesis inhibitors can down-regulate transcription of virulence factor genes, mimicking RNAIII mutations, Balaban and Novick postulated that intermediary factors are required for transcription of virulence factor genes (2). Negative regulators of virulence factor genes constitute one possible class of these molecules. To identify loci that encode repressors, we subjected strain PM466 to mutagenesis with transposon Tn917 and screened for the restoration of two extracellular virulence factor activities.
S. aureus PM466, a genetically defined agr-null strain, was constructed for this study. PM466 is a derivative of RN6390, the wild-type strain used to define the molecular genetics of agr and sar (6, 34). In contrast to S. aureus RN6911, the published RN6390-derived agr-null mutant strain, PM466 has a specific deletion rather than an antibiotic marker and an accompanying deletion of unknown extent (33). Despite this genetic difference, quantitative measurements of cell surface and extracellular proteins suggest that the two agr-null strains have a common phenotype (data not shown). This observation supports previous findings in which the changes seen in RN6911 were interpreted as being solely due to the inactivation of agr.
Initially, we screened transposon Tn917 mutants for restored
protease activity. Although the protein or proteins responsible for the
zone of proteolysis surrounding single colonies of bacteria on skim
milk agar have not been definitively identified, this activity has been
shown to be RNAIII dependent (9). Wild-type strains produce
clear zones of proteolysis on indicator plates, while the
agr-null strains RN6911 and PM466 lack this activity (our
unpublished data). To rule out mutations in genes that only up-regulate
protease expression in the agr genetic background, the
protease-positive strains were screened for hemolytic activity. S. aureus produces four different hemolysins (alpha-, beta-,
delta- and gamma-toxins); however, rabbit erythrocytes suspended in
agar are only susceptible to the action of alpha- and delta-toxins (14). Since the agr deletion in PM466 encompasses
the gene encoding delta-toxin, the hemolytic activity associated with
mutants created in the PM466 background is due to alpha-toxin
(34). Despite the fact that RNAIII has been reported to be
required for alpha-toxin translation, several of the proteolytic
mutants displayed a hemolytic phenotype (28).
Cotransductional analysis of the proteolytic- and alpha-toxin-positive
mutants was used to verify genetic linkage between the extracellular
protein phenotype and the erythromycin resistance encoded by the
transposon. Finally, the phenotype associated with the rot
allele in the agr-null strains was confirmed by
demonstrating that wild-type rot is sufficient to restore an
Agr
phenotype to PM614.
The rot locus has limited amino acid sequence homology with the known staphylococcal transcriptional regulators AgrA and SarA. The lack of structure and function data for AgrA and SarA precludes assigning a specific biological significance to the homologous region. Genetic experiments have suggested that AgrA is an activator of agr; however, AgrA has not been shown to bind DNA within the agr promoter region (29). Recent evidence suggests that SarA is a DNA-binding protein that activates both agr and individual virulence factor genes (4, 6). While it is not possible to exclude the hypothesis that the rot gene product is a component of a protein complex or the activator of a repressor, the limited homology among the regulatory genes and the phenotype conferred by the rot::Tn917 mutation suggests that the rot-encoded protein is a transcriptional repressor. In addition to those encoded by sar and agr, two uncharacterized proteins were identified by searches that used the predicted rot translation product. We have cloned the genes for these proteins and have produced knockout mutants in S. aureus.
Quantitative measurements of alpha-toxin activity and Northern analysis of the corresponding message were used to verify rot and, in part, to define its activity. Measurements of alpha-toxin activity indicated that restoration of rot in PM614 completely represses alpha-toxin to agr levels. Moreover, rot mutations were found to only partially restore alpha-toxin activity to agr-null strains. This observation may be explained by the translational effect of RNAIII on the alpha-toxin message, although the mirroring of alpha-toxin activity and message in PM614 suggests that regulation occurs at the level of transcription. Therefore, it is possible that the rot-encoded protein may up-regulate an activator that is necessary for full alpha-toxin expression.
Collectively, our data suggest that rot encodes a repressor of extracellular virulence factor transcription. We are testing a direct model (Fig. 1B) that predicts that the rot gene product (Rot) binds within the promoter region of regulated genes during the lag and exponential phase of bacterial growth, blocking their transcription. Transcription of Rot-regulated promoters occurs when levels of the bound repressor are decreased, thus exposing the promoter and allowing the binding of transcriptional activators and RNA polymerase. This model is analogous to the H-NS-DsrA-RNA pathway of E. coli (37). In the E. coli system, DrsA-RNA is part of a complex that binds the histone-like protein (H-NS), thus relieving DNA secondary structure that inhibits the transcription of regulated genes (24). A competing hypothesis is that rot and agr encode components of independent, yet partially redundant, pathways. Under this scenario, the rot translation product may act as either a repressor or an activator of factors necessary for virulence factor synthesis. In either case, the rot-associated activity appears to be altered by an agr product or factors that are regulated by agr, because the rot mutation does not alter alpha-toxin expression found in culture supernatant fluids from stationary cultures of wild-type strains.
| |
ACKNOWLEDGMENTS |
|---|
We thank Rae Ellen Syverson and Donna Bates for their helpful discussions and critical reading of this manuscript. This work was supported by the American Heart Association Beginning Grant-in-Aid (9960328Z) to P.J.M. and U.S. Public Health Service grant R01 AI42072-02 from the National Institute of Allergy and Infectious Diseases to R.A.P.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Medical Microbiology and Immunology, 407 Service Memorial Institute, University of Wisconsin Medical School, Madison, WI 53706. Phone: (608) 263-2188. Fax: (608) 262-8418. E-mail: pjmcnamara{at}facstaff.wisc.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ausubel, F. A., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1996. Current protocols in molecular Biology. Greene Publishing and Wiley-Interscience, New York, N.Y. |
| 2. | Balaban, N., and R. P. Novick. 1995. Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3'-end deletion. FEMS Microbiol. Lett. 133:155-161[Medline]. |
| 3. |
Bayer, M. G.,
J. H. Heinrichs, and A. L. Cheung.
1996.
The molecular architecture of the sar locus in Staphylococcus aureus.
J. Bacteriol.
178:4563-4570 |
| 4. |
Chan, P. F., and S. J. Foster.
1998.
The Staphylococcus aureus alternative sigma factor B controls the environmental stress response but not starvation survival or pathogenicity in a mouse abscess model.
J. Bacteriol.
180:6232-6241 |
| 5. |
Cheung, A. L.,
J. M. Koomey,
C. A. Butler,
S. J. Projan, and V. A. Fischetti.
1992.
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr.
Proc. Natl. Acad. Sci. USA
89:6462-6466 |
| 6. |
Cheung, A. L., and S. J. Projan.
1994.
Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr.
J. Bacteriol.
176:4168-4172 |
| 7. |
Cheung, A. L.,
C. Woltz,
M. R. Yeaman, and A. S. Bayer.
1995.
Insertional inactivation of a chromosomal locus that modulates expression of potential virulence determinants in Staphylococcus aureus.
J. Bacteriol.
177:3220-3226 |
| 8. | Cheung, A. L., K. Eberhardt, and J. H. Heinrichs. 1997. Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus. Infect. Immun. 65:2243-2249[Abstract]. |
| 9. | Chien, Y., A. C. Manna, S. J. Projan, and A. L. Cheung. 1999. SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J. Biol. Chem. 24:37169-37176. |
| 10. | Coen, D. 1992. Enzymatic amplification of DNA by PCR: standard procedures and optimization, p. 15.1.1-15.1.7. In F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing and Wiley-Interscience, New York, N.Y. |
| 11. |
Compagnone-Post, P.,
U. Malyankar, and S. A. Khan.
1991.
Role of host factors in the regulation of the enterotoxin B gene.
J. Bacteriol.
173:1827-1830 |
| 12. | Dassy, B., T. Hogan, T. J. Foster, and M. Fournier. 1993. Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J. Gen. Microbiol. 139:1301-1306. |
| 13. |
Dyer, D. W., and J. J. Iandolo.
1983.
Rapid isolation of DNA from Staphylococcus aureus.
Appl. Environ. Microbiol.
46:283-285 |
| 14. | Elek, S., and E. Levy. 1950. Distribution of haemolysin in pathogenic and non-pathogenic staphylococci. J. Pathol. Bacteriol. 62:541-554[CrossRef][Medline]. |
| 15. |
Hart, M. E.,
M. S. Smeltzer, and J. J. Iandolo.
1993.
Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus.
Infect. Immun.
61:919-925 |
| 16. |
Heinrichs, J. H.,
M. G. Bayer, and A. L. Cheung.
1996.
Characterization of the sar locus and its interaction with agr in Staphylococcus aureus.
J. Bacteriol.
178:418-423 |
| 17. | Janzon, L., and S. Arvidson. 1990. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J. 9:1391-1399[Medline]. |
| 18. |
Ji, G.,
R. C. Beavis, and R. P. Novick.
1995.
Cell density control of staphylococcal virulence mediated by an octapeptide pheromone.
Proc. Natl. Acad. Sci. USA
92:12055-12059 |
| 19. |
Ji, G.,
R. C. Beavis, and R. P. Novick.
1997.
Bacterial interference caused by autoinducing peptide variants.
Science
276:2027-2030 |
| 20. | Jones, R. N. 1996. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am. J. Med. 24:3S-12S. |
| 21. | Kornblum, J., N. Kreiswirth, S. J. Projan, H. Ross, and R. P. Novick. 1990. agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus, p. 373-402. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH, New York, N.Y. |
| 22. | Kraemer, G. R., and J. J. Iandolo. 1990. High-frequency transformation of Staphylococcus aureus by electroporation. Curr. Microbiol. 21:373-376[CrossRef]. |
| 23. |
Kullik, I.,
P. Giachino, and T. Fuchs.
1998.
Deletion of the alternative sigma factor B in Staphylococcus aureus reveals its function as a global regulator of virulence genes.
J. Bacteriol.
180:4814-4820 |
| 24. |
Lease, R. A.,
M. E. Cusick, and M. Belfort.
1998.
Riboregulation in Escherichia coli: DsrA RNA acts by RNA:RNA interactions at multiple loci.
Proc. Natl. Acad. Sci. USA
95:12456-12461 |
| 25. | Lina, G., S. Jarraurd, G. Ji, T. Greenland, A. Pedraza, J. Etienne, R. P. Novick, and F. Vandenesch. 1998. Transmembrane topology and histidine kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol. Microbiol 28:655-662[CrossRef][Medline]. |
| 26. |
Lyon, B. R., and R. Skurray.
1987.
Antimicrobial resistance of Staphylococcus aureus: genetic basis.
Microbiol. Rev.
51:88-134 |
| 27. |
McNamara, P. J., and J. J. Iandolo.
1998.
Genetic instability of the global regulator agr explains the phenotype of the xpr mutation in Staphylococcus aureus KSI9051.
J. Bacteriol.
180:2609-2615 |
| 28. | Morfeldt, E., D. Taylor, A. von Gabain, and S. Arvidson. 1995. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 14:4569-4577[Medline]. |
| 29. | Morfeldt, E., K. Tegmark, and S. Arvidson. 1996. Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. Mol. Microbiol. 21:1227-1237[CrossRef][Medline]. |
| 30. | Novick, R. 1995. Signal transduction in staphylococci and other gram-positive cocci, p. 39-53. In R. Rappuoli, V. Scarlato, and B. Aricò (ed.), Signal transduction and bacterial virulence. R. G. Landes Company, Austin, Tex. |
| 31. | Novick, R., J. Kornblum, B. Kreiswirth, S. Projan, and H. Ross. 1990. Regulation of postexponential phase exoprotein synthesis in Staphylococcus aureus, p. 9-18. In E. M. Ayout, G. H. Cassell, W. C. Branche, and T. J. Henery (ed.), Microbial determinants of virulence and host responses. American Society for Microbiology, Washington, D.C. |
| 32. | Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975[Medline]. |
| 33. | Novick, R. P., S. J. Projan, J. Kornblum, H. F. Ross, G. Ji, B. Kreiswirth, F. Vandenesch, and S. Moghazeh. 1995. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248:446-458[CrossRef][Medline]. |
| 34. |
Peng, H.-I.,
R. P. Novick,
B. Kreiswirth,
J. Kornblum, and P. Schlievert.
1988.
Cloning, characterization, and sequence of an accessory gene regulator (agr) in Staphylococcus aureus.
J. Bacteriol.
170:4365-4372 |
| 35. |
Regassa, L. B.,
R. P. Novick, and M. J. Betley.
1992.
Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus.
Infect. Immun.
60:3381-3388 |
| 36. | Skurray, R. A., and N. Firth. 1997. Molecular evolution of multiply-antibiotic-resistant staphylococci. Ciba Found. Symp. 207:167-183[Medline]. |
| 37. | Sledjeski, D. D., A. Gupta, and S. Gottesman. 1996. The small RNA, dsrA, is essential for the low temperature expression of rpoS during exponential growth in Escherichia coli. EMBO J. 15:3993-4000[Medline]. |
| 38. | Smibert, R. M., and N. R. Krieg. 1981. General characterization, p. 435. In N. Krieg (ed.), Manual of methods for general bacteriology. American Society for Microbiology, Washington, D.C. |
| 39. |
Vandenesch, F.,
J. Kornblum, and R. P. Novick.
1991.
A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus.
J. Bacteriol.
173:6313-6320 |
| 40. |
Wu, S.,
H. de Lancastre, and A. Tomaz.
1996.
Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing.
J. Bacteriol.
178:6036-6942 |
| 41. | Youngman, P. 1987. Plasmid vectors for recovering and exploiting Tn917 transpositions in Bacillus and other gram-positive bacteria, p. 79-103. In K. G. Hardy (ed.), Plasmids: a practical approach. IRL Press Limited, Oxford, United Kingdom. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |